Delivery Order SPE2DB22D1017-SPE2DB24FF8CF
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the supply of Lidocaine 5% Patches. The contract has a ceiling value of $1,287.86 and a completion date of May 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract is a Delivery Order with a Firm Fixed Price type and a ceiling value of $2,339.48. The contract has an ultimate completion date of November 22, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Lidocaine 5% patches, a type of prescription medication. The contract has a ceiling value of $5,888.70 and an ultimate completion date of June 25, 2024. It is a firm-fixed-price delivery order contract, meaning Amerisourcebergen will be paid a pre-determined amount for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lidocaine 5% patches, with a ceiling value of $15,432.59 and a period of performance through February 7, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Lidocaine 5% Patch 30S. The contract, which is not set aside, has a ceiling value of $7,131.04 and an ultimate completion date of December 16, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of Lidocaine 5% Patches, a pharmaceutical product used for pain management. The contract has a firm fixed price and a ceiling value of $12,208.72, with a period of performance through January 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Lidocaine 5% Patches to support federal healthcare programs. The $2,732.06 contract has an ultimate completion date of July 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to deliver a broad range of medical commodities to military treatment facilities...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lidocaine 5% Patches, with a total ceiling value of $5,005.80 and an ultimate completion date of June 23, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The Firm Fixed Price delivery order, valued at $2,744.04, has an ultimate completion date of May 15, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,760.77 contract is for the delivery of Lidocaine 5% Patches. The contract has an ultimate completion date of July 17, 2025 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF8CFDelivery Order
This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lidocaine 5% Patches. The contract has a ceiling value of $9,738.57 and an ultimate completion date of May 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award is not designated as a set-aside.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 5/21/24 |